524322 KABRADG

Kabra Drugs Share Price

 

 

Start SIP in KABRADG

Start SIP

Performance

  • Low
  • ₹27
  • High
  • ₹28
  • 52 Week Low
  • ₹10
  • 52 Week High
  • ₹33
  • Open Price₹28
  • Previous Close₹28
  • Volume35,765
  • 50 DMA₹26.95
  • 100 DMA₹23.97
  • 200 DMA₹19.44

Investment Returns

  • Over 1 Month + 3.44%
  • Over 3 Month + 43.58%
  • Over 6 Month + 37.5%
  • Over 1 Year + 177.73%

Smart Investing Starts Here Start SIP with Kabra Drugs for Steady Growth!

Invest Now

Kabra Drugs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 55.5
  • PEG Ratio
  • 0.3
  • Market Cap Cr
  • 66
  • P/B Ratio
  • 2.5
  • Average True Range
  • 1.68
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • 0.54
  • RSI
  • 46.74
  • MFI
  • 62.26

Kabra Drugs Financials

Kabra Drugs Technicals

EMA & SMA

Current Price
₹27.94
+ 0.07 (0.25%)
pointer
  • Bearish Moving Average 9
  • Bullish Moving Average 7
  • 20 Day
  • ₹28.56
  • 50 Day
  • ₹26.95
  • 100 Day
  • ₹23.97
  • 200 Day
  • ₹19.44

Resistance and Support

27.71 Pivot Speed
  • R3 29.66
  • R2 28.99
  • R1 28.38
  • S1 27.10
  • S2 26.43
  • S3 25.82

Kabra Drugs Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-28 Others Inter alia, To sign an agreement with MR FRANCHISE to appoint around 200 channel partner throughout the Country for expansion.
2025-11-13 Quarterly Results
2025-10-08 Others Inter-aliam to consider 1.Approve the final draft of the Share Purchase Agreement (SPA) in relation to the acquisition of AMR PHARMA INDIA PRIVATE LIMITED. 2. Other business matters.
2025-09-02 Others Inter-alia, to consider 1. Directors Report and Corporate Governance Report for the financial year 2024 -25. 2. Draft Notice calling the AGM. 3. Other business matters.
2025-08-14 Quarterly Results

Kabra Drugs F&O

Kabra Drugs Shareholding Pattern

0%
95%
5%

About Kabra Drugs

  • NSE Symbol
  • KABRADG
  • BSE Symbol
  • 524322
  • Managing Director
  • Mr. N Aravind
  • ISIN
  • INE323K01017

Similar Stocks to Kabra Drugs

Kabra Drugs FAQs

Kabra Drugs share price is ₹27 As on 18 January, 2026 | 05:55

The Market Cap of Kabra Drugs is ₹66.2 Cr As on 18 January, 2026 | 05:55

The P/E ratio of Kabra Drugs is 55.5 As on 18 January, 2026 | 05:55

The PB ratio of Kabra Drugs is 2.5 As on 18 January, 2026 | 05:55

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23